Greenwich LifeSciences, Inc.
GLSI· Nasdaq
Released Nov 15, 2021, after the close
10-Q filed Nov 15, 2021, 46 days after period end · 0001493152-21-028660
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|
| Net Income | -$863.12K | -$256.87K | -$336.01K |
| EPS Diluted | -$0.07 | -$0.03 | -$1.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end
2.7% from the close of Nov 11, 2021 to the close of Nov 18, 2021, the first after the release.